Skip to main content
CSTE
NASDAQ Manufacturing

Caesarstone Reports Worsening Q1 Loss Amid Revenue Decline, Massive Silicosis Liability, and Tariff Risks

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
9
Price
$1.32
Mkt Cap
$45.642M
52W Low
$0.558
52W High
$2.58
Market data snapshot near publication time

summarizeSummary

Caesarstone reported a widened Q1 net loss and revenue decline, compounded by a $48.8 million silicosis liability exceeding its market cap and new U.S. tariff threats, despite some gross margin improvement.


check_boxKey Events

  • Worsening Financial Performance

    Q1 2026 net loss widened to $21.1 million ($0.61 per share) from $12.9 million ($0.26 per share) in Q1 2025, with operating loss also increasing to $19.4 million.

  • Significant Revenue Decline

    Revenue fell 10.9% year-over-year to $88.7 million, reflecting continued softness in global demand and competitive pressures, particularly in North America.

  • Massive Silicosis Legal Liability

    The company recorded a provision of $48.8 million for 711 silicosis claims, an amount that significantly exceeds its current market capitalization, posing a severe financial risk.

  • New Tariff Overhang

    The U.S. International Trade Commission recommended a four-year tariff-rate quota structure (25-40% ad valorem) on quartz surface product imports, with a presidential decision expected within 60 days, creating significant uncertainty for U.S. operations.


auto_awesomeAnalysis

Caesarstone's first-quarter results show a significant deterioration in net loss and revenue, continuing a negative financial trend. The company's net loss widened to $21.1 million, and revenue declined by 10.9% year-over-year, reflecting persistent weakness in global demand. Critically, the company faces a provision of $48.8 million for silicosis-related legal claims, an amount that exceeds its entire market capitalization, posing an existential threat. Additionally, new U.S. tariff recommendations on quartz imports create substantial uncertainty and potential cost increases. While gross margin improved and the company targets positive Adjusted EBITDA by Q3 2026, these operational positives are heavily overshadowed by the magnitude of current losses, the massive legal liability, and significant external trade risks.

At the time of this filing, CSTE was trading at $1.32 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $45.6M. The 52-week trading range was $0.56 to $2.58. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CSTE - Latest Insights

CSTE
May 13, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
9
CSTE
May 13, 2026, 7:12 AM EDT
Source: Reuters
Importance Score:
7
CSTE
Mar 04, 2026, 5:13 PM EST
Filing Type: 20-F
Importance Score:
10
CSTE
Mar 04, 2026, 9:18 AM EST
Filing Type: 6-K
Importance Score:
10
CSTE
Mar 04, 2026, 7:10 AM EST
Source: Reuters
Importance Score:
8
CSTE
Mar 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
8